97 related articles for article (PubMed ID: 15603947)
1. Tubulin-polymerization inhibitors derived from thalidomide.
Inatsuki S; Noguchi T; Miyachi H; Oda S; Iguchi T; Kizaki M; Hashimoto Y; Kobayashi H
Bioorg Med Chem Lett; 2005 Jan; 15(2):321-5. PubMed ID: 15603947
[TBL] [Abstract][Full Text] [Related]
2. Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: possible anti-myeloma mechanism of thalidomide.
Iguchi T; Yachide-Noguchi T; Hashimoto Y; Nakazato S; Sagawa M; Ikeda Y; Kizaki M
Int J Mol Med; 2008 Feb; 21(2):163-8. PubMed ID: 18204782
[TBL] [Abstract][Full Text] [Related]
3. New tubulin polymerization inhibitor derived from thalidomide: implications for anti-myeloma therapy.
Kizaki M; Hashimoto Y
Curr Med Chem; 2008; 15(8):754-65. PubMed ID: 18393844
[TBL] [Abstract][Full Text] [Related]
4. Development of tubulin-polymerization inhibitors based on the thalidomide skeleton.
Aoyama H; Noguchi T; Misawa T; Nakamura T; Miyachi H; Hashimoto Y; Kobayashi H
Chem Pharm Bull (Tokyo); 2007 Jun; 55(6):944-9. PubMed ID: 17541201
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis inhibitors derived from thalidomide.
Noguchi T; Fujimoto H; Sano H; Miyajima A; Miyachi H; Hashimoto Y
Bioorg Med Chem Lett; 2005 Dec; 15(24):5509-13. PubMed ID: 16183272
[TBL] [Abstract][Full Text] [Related]
6. A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities.
Li PK; Pandit B; Sackett DL; Hu Z; Zink J; Zhi J; Freeman D; Robey RW; Werbovetz K; Lewis A; Li C
Mol Cancer Ther; 2006 Feb; 5(2):450-6. PubMed ID: 16505120
[TBL] [Abstract][Full Text] [Related]
7. Tubulin polymerization inhibitors with a fluorinated phthalimide skeleton derived from thalidomide.
Yanagawa T; Noguchi T; Miyachi H; Kobayashi H; Hashimoto Y
Bioorg Med Chem Lett; 2006 Sep; 16(18):4748-51. PubMed ID: 16870433
[TBL] [Abstract][Full Text] [Related]
8. Thalidomide (5HPP-33) suppresses microtubule dynamics and depolymerizes the microtubule network by binding at the vinblastine binding site on tubulin.
Rashid A; Kuppa A; Kunwar A; Panda D
Biochemistry; 2015 Mar; 54(12):2149-59. PubMed ID: 25747795
[TBL] [Abstract][Full Text] [Related]
9. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.
Coluccia A; Sabbadin D; Brancale A
Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885
[TBL] [Abstract][Full Text] [Related]
10. Cell differentiation inducers derived from thalidomide.
Noguchi T; Miyachi H; Katayama R; Naito M; Hashimoto Y
Bioorg Med Chem Lett; 2005 Jul; 15(13):3212-5. PubMed ID: 15936192
[TBL] [Abstract][Full Text] [Related]
11. Indole, a core nucleus for potent inhibitors of tubulin polymerization.
Brancale A; Silvestri R
Med Res Rev; 2007 Mar; 27(2):209-38. PubMed ID: 16788980
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitors of tubulin assembly: specially on rhizoxin-maytansine site ligands].
Iwasaki S
Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1742-52. PubMed ID: 8210422
[No Abstract] [Full Text] [Related]
13. Inhibition of tubulin polymerization by 5,6-dihydroindolo[2,1-alpha]isoquinoline derivatives.
Goldbrunner M; Loidl G; Polossek T; Mannschreck A; von Angerer E
J Med Chem; 1997 Oct; 40(22):3524-33. PubMed ID: 9357519
[TBL] [Abstract][Full Text] [Related]
14. Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization.
Gastpar R; Goldbrunner M; Marko D; von Angerer E
J Med Chem; 1998 Dec; 41(25):4965-72. PubMed ID: 9836614
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship studies of thalidomide analogs with a taxol-like mode of action.
Pandit B; Hu Z; Chettiar SN; Zink J; Xiao Z; Etter JP; Bhasin D; Li PK
Bioorg Med Chem Lett; 2013 Dec; 23(24):6902-4. PubMed ID: 24169233
[TBL] [Abstract][Full Text] [Related]
16. Arylthioindoles, potent inhibitors of tubulin polymerization.
De Martino G; La Regina G; Coluccia A; Edler MC; Barbera MC; Brancale A; Wilcox E; Hamel E; Artico M; Silvestri R
J Med Chem; 2004 Dec; 47(25):6120-3. PubMed ID: 15566282
[TBL] [Abstract][Full Text] [Related]
17. Endowing indole-based tubulin inhibitors with an anchor for derivatization: highly potent 3-substituted indolephenstatins and indoleisocombretastatins.
Álvarez R; Puebla P; Díaz JF; Bento AC; García-Navas R; de la Iglesia-Vicente J; Mollinedo F; Andreu JM; Medarde M; Peláez R
J Med Chem; 2013 Apr; 56(7):2813-27. PubMed ID: 23470139
[TBL] [Abstract][Full Text] [Related]
18. 7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents.
Chang JY; Hsieh HP; Chang CY; Hsu KS; Chiang YF; Chen CM; Kuo CC; Liou JP
J Med Chem; 2006 Nov; 49(23):6656-9. PubMed ID: 17154496
[TBL] [Abstract][Full Text] [Related]
19. New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies.
De Martino G; Edler MC; La Regina G; Coluccia A; Barbera MC; Barrow D; Nicholson RI; Chiosis G; Brancale A; Hamel E; Artico M; Silvestri R
J Med Chem; 2006 Feb; 49(3):947-54. PubMed ID: 16451061
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 2,4,5-substituted pyrimidines as a new class of tubulin polymerization inhibitors.
Xie F; Zhao H; Li D; Chen H; Quan H; Shi X; Lou L; Hu Y
J Med Chem; 2011 May; 54(9):3200-5. PubMed ID: 21480626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
